Prolight Diagnostics ABNGM: PRLD

Prolight Diagnostics publishes investor letter for November 2025

· Issued by Prolight Diagnostics AB

The investor letter notes, among other things that Prolight takes clear steps toward commercialization of the Psyros™ POC system.

The investor letter is available via the attached file or on the company’s website: https://prolightdx.com/en/mediaeng/investor-letters/

Prolight Diagnostics AB on 6ix

Earlier from Prolight Diagnostics

Later from Prolight Diagnostics

All Prolight Diagnostics news releases